Amid an outbreak of infant botulism caused by Byheart baby formula, Dawn Nolt, M.D., advises parents to contact their child’s clinician if their infant has consumed Byheart formula and is experiencing symptoms of botulism: “It causes profound weakness, constipation, difficulty swallowing, and so even though infant botulism is quite rate, it certainly is a very serious disease.”

At his monthly media availability, Shereef Elnahal, M.D., voices concerns about potential cuts to the 340-B program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients.

OHSU researchers have developed a new molecule that offers a promising avenue to treat intractable cases of triple-negative breast cancer. Sanjay Malhotra, Ph.D., says, “We're very excited. The good part is it is not at the discovery stage. Discovery is already done, and discovery has led to this exciting outcome. Now it's at the development stage, which is where we need resources to bring it to clinic."

Bloomberg TV’s Wall Street Week reports on the broken state of pediatric health care financing. Ben Hoffman, M.D., explains that insurance payment structures reimburse pediatric health care services at significantly lower rates than adult services, which inherently puts children at a disadvantage: “Children are 30% of our population but 100% of our future … Cobbling together something with the crumbs or what’s left over from the adult system is just not going to work.”

OHSU researchers have developed a new molecule that offers a promising avenue to treat intractable cases of triple-negative breast cancer. Sanjay Malhotra, Ph.D., says, “We're very excited. The good part is it is not at the discovery stage. Discovery is already done, and discovery has led to this exciting outcome. Now it's at the development stage, which is where we need resources to bring it to clinic."

OHSU researchers have developed a new molecule that offers a promising avenue to treat intractable cases of triple-negative breast cancer. Sanjay Malhotra, Ph.D., says, “We're very excited. The good part is it is not at the discovery stage. Discovery is already done, and discovery has led to this exciting outcome. Now it's at the development stage, which is where we need resources to bring it to clinic."

Claudia Aime, D.N.P., RN, chief nursing officer at OHSU, is recognized as one of the top 50 leaders of Portland for 2025.

A novel multi-cancer early detection test shows promise in initial clinical trials. Nima Nabavizadeh, M.D., says, “It was clear to me, as we were running the study, that we were picking up some novel cancers at an early stage that we previously had no means of detecting … These are largely cancers that we're normally, outside of these blood tests, just waiting to find them, either incidentally or because somebody has symptoms associated with them."

Phil and Penny Knight’s recent $2 billion donation to the Knight Cancer Institute is mentioned in a Forbes article highlighting major donations to HBCUs, noting it as the largest single pledge to a university ever.

The New York Times reports on considerations for use of melatonin, including research pointing to its potential risks for heart health. Andrew McHill, Ph.D., notes taking melatonin can help you adjust to a new time zone or shift your sleep schedule but is not an effective insomnia fix.